Cargando…

Effect of aerobic exercise training and cognitive behavioural therapy on reduction of chronic fatigue in patients with facioscapulohumeral dystrophy: protocol of the FACTS-2-FSHD trial

BACKGROUND: In facioscapulohumeral dystrophy (FSHD) muscle function is impaired and declines over time. Currently there is no effective treatment available to slow down this decline. We have previously reported that loss of muscle strength contributes to chronic fatigue through a decreased level of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voet, Nicoline BM, Bleijenberg, Gijs, Padberg, George W, van Engelen, Baziel GM, Geurts, Alexander CH
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906431/ https://www.ncbi.nlm.nih.gov/pubmed/20591139 http://dx.doi.org/10.1186/1471-2377-10-56

Ejemplares similares

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy
por: van der Kooi, E. L., et al.
Publicado: (2007)

The facioscapulohumeral muscular dystrophy Rasch‐built overall disability scale (FSHD‐RODS)
por: Mul, Karlien, et al.
Publicado: (2021)

The FSHD muscle–blood biomarker: a circulating transcriptomic biomarker for clinical severity in facioscapulohumeral muscular dystrophy
por: Banerji, Christopher R S, et al.
Publicado: (2023)

Distinct Disease Phases in Muscles of Facioscapulohumeral Dystrophy Patients Identified by MR Detected Fat Infiltration
por: Janssen, Barbara H., et al.
Publicado: (2014)

Cardiac Involvement in Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Ducharme-Smith, Allison, et al.
Publicado: (2021)

UK Facioscapulohumeral Muscular Dystrophy (FSHD) Patient Registry
por: Wood, Libby, et al.
Publicado: (2014)

Ophthalmological findings in facioscapulohumeral dystrophy
por: Goselink, Rianne J M, et al.
Publicado: (2019)

Orofacial Muscle Weakening in Facioscapulohumeral Muscular Dystrophy (FSHD) Patients
por: Konstantonis, Dimitrios, et al.
Publicado: (2022)

Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD): A Systematic Review
por: Aguirre, Alex S, et al.
Publicado: (2023)

Facioscapulohumeral muscular dystrophy (FSHD) and multiple sclerosis: a case report
por: Iodice, Rosa, et al.
Publicado: (2020)

Consequences of epigenetic derepression in facioscapulohumeral muscular dystrophy
por: Greco, Anna, et al.
Publicado: (2020)

Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
por: Lemmers, Richard J.L.F., et al.
Publicado: (2012)

Determining the role of sarcomeric proteins in facioscapulohumeral muscular dystrophy: a study protocol
por: Lassche, Saskia, et al.
Publicado: (2013)

The socioeconomic burden of facioscapulohumeral muscular dystrophy
por: Blokhuis, Anna M., et al.
Publicado: (2021)

Anticipation Avoids Adversity: Anesthetic Management of a Case of Facioscapulohumeral Dystrophy (FSHD)
por: Ahamed, Seyed, et al.
Publicado: (2023)

Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD)
por: Goselink, Rianne J. M., et al.
Publicado: (2016)

Rasch analysis to evaluate the motor function measure for patients with facioscapulohumeral muscular dystrophy
por: Mul, Karlien, et al.
Publicado: (2020)

Reduced specific force in patients with mild and severe facioscapulohumeral muscular dystrophy
por: Lassche, Saskia, et al.
Publicado: (2020)

Altered Expression of Cyclin A 1 In Muscle of Patients with Facioscapulohumeral Muscle Dystrophy (FSHD-1)
por: Pakula, Anna, et al.
Publicado: (2013)

Telomere Position Effect (TPE) Regulates DUX4 in Human Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Stadler, Guido, et al.
Publicado: (2013)

Characterizing the face in facioscapulohumeral muscular dystrophy
por: Loonen, T. G. J., et al.
Publicado: (2020)

Molecular Diagnosis of Facioscapulohumeral Muscular Dystrophy in Patients Clinically Suspected of FSHD Using Optical Genome Mapping
por: Guruju, Naga M., et al.
Publicado: (2023)

Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation
por: Bodega, Beatrice, et al.
Publicado: (2009)

Transgenic Drosophila for Investigating DUX4 and FRG1, Two Genes Associated with Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Jones, Takako I., et al.
Publicado: (2016)

A cross sectional study of two independent cohorts identifies serum biomarkers for facioscapulohumeral muscular dystrophy (FSHD)
por: Petek, Lisa M., et al.
Publicado: (2016)

A case of type 1 facioscapulohumeral muscular dystrophy (FSHD) with restrictive ventilatory defect and congestive heart failure
por: Morimoto, Nobutoshi, et al.
Publicado: (2020)

Natural History of Facioscapulohumeral Dystrophy in Children: A 2-Year Follow-up
por: Dijkstra, Jildou N., et al.
Publicado: (2021)

184th ENMC international workshop: Pain and fatigue in neuromuscular disorders(): 20–22 May 2011, Naarden, The Netherlands
por: de Groot, Imelda J.M., et al.
Publicado: (2013)

Quantitative muscle MRI and ultrasound for facioscapulohumeral muscular dystrophy: complementary imaging biomarkers
por: Mul, Karlien, et al.
Publicado: (2018)

Facioscapulohumeral Dystrophy in Childhood: A Nationwide Natural History Study
por: Goselink, Rianne J.M., et al.
Publicado: (2018)

Long-term follow-up of respiratory function in facioscapulohumeral muscular dystrophy
por: Teeselink, Sjan, et al.
Publicado: (2022)

A pilot study of a single intermittent arm cycling exercise programme on people affected by Facioscapulohumeral dystrophy (FSHD)
por: Philp, Fraser, et al.
Publicado: (2022)

Profiling Serum Antibodies Against Muscle Antigens in Facioscapulohumeral Muscular Dystrophy Finds No Disease-Specific Autoantibodies
por: Greco, Anna, et al.
Publicado: (2021)

Five‐year follow‐up study on quantitative muscle magnetic resonance imaging in facioscapulohumeral muscular dystrophy: The link to clinical outcome
por: Vincenten, Sanne C.C., et al.
Publicado: (2023)

Rbfox1 Downregulation and Altered Calpain 3 Splicing by FRG1 in a Mouse Model of Facioscapulohumeral Muscular Dystrophy (FSHD)
por: Pistoni, Mariaelena, et al.
Publicado: (2013)

Single-molecule optical mapping enables quantitative measurement of D4Z4 repeats in facioscapulohumeral muscular dystrophy (FSHD)
por: Dai, Yi, et al.
Publicado: (2020)

Smartphone and Wearable Sensors for the Estimation of Facioscapulohumeral Muscular Dystrophy Disease Severity: Cross-sectional Study
por: Zhuparris, Ahnjili, et al.
Publicado: (2023)

Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial
por: van Engelen, Baziel
Publicado: (2015)

Facioscapulohumeral muscular dystrophy and respiratory failure; what about the diaphragm?
por: Hazenberg, A., et al.
Publicado: (2014)

Objective Monitoring of Facioscapulohumeral Dystrophy During Clinical Trials Using a Smartphone App and Wearables: Observational Study
por: Maleki, Ghobad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8chol0qgrcdmccjc5eon9l76j6